Delving into the Latest Updates on CARDIX-101 with Synapse

Overview

Basic Info

Drug Type

Unknown

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

Cardiovascular Diseases

Active Indication

Bradycardia

Inactive Indication-

Originator Organization-

Active Organization

Cardix Therapeutics LLC

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

The treatment of chronic bradycardia, one of the cardiovascular diseases, remains an essential unsolved issue. The objective of this project is to speed up a new drug CARDIX-101 clinical Phase 1IA trial for the treatment of chronic bradycardia and to solve an unmet medical need.
To date, there is no regulatory approved drug of this type available in the U.S or the world. If the new drug CARDIX-101 demonstrated a significant positive effect on chronic bradycardia, it should have a sizeable demand and solve an unmet medical need.

Start Date01 Dec 2022

Sponsor / Collaborator

Cardix Therapeutics LLC

100 Clinical Results associated with CARDIX-101

Login to view more data

100 Translational Medicine associated with CARDIX-101

Login to view more data

100 Patents (Medical) associated with CARDIX-101

Login to view more data

100 Deals associated with CARDIX-101

Login to view more data